Post-covid China: ‘vaccine diplomacy’ and the new developments of Chinese foreign policy

Kobierecka, Anna

doi:10.1057/s41254-022-00266-2

Cited by 18 publications

(17 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The COVID-19 pandemic has presented China with a window of opportunity to uplift its international image and influence through vaccine diplomacy. China uses vaccine diplomacy to contribute to its nation branding and present itself in a successful and responsible role against the pandemic [ 1 , 60 ]. China has also been motivated to launch vaccine diplomacy for its comprehensive national security and commitment to building a Health Silk Road for Cooperation.…”

Section: Discussionmentioning

confidence: 99%

China’s Vaccine Diplomacy and Its Implications for Global Health Governance

2022

View full text Add to dashboard Cite

The COVID-19 pandemic has wreaked havoc on global economy and human communities. Promoting the accessibility and affordability of vaccine via diplomacy is the key to mitigating the pandemic crisis. China has been accused of seeking geopolitical objectives by launching vaccine diplomacy. The definition of vaccine diplomacy is neutral by nature. China’s vaccine diplomacy is based on its holistic approach to national security and the importance China attaches to the “Belt and Road” Initiative. With a whole-of-government approach on both the bilateral and multilateral levels and marketization of vaccines, China’s vaccine diplomacy has immense implications for global health governance, in that it helps to narrow the global immunization vaccination gap and to promote human-right-based approach to global health governance. However, the sustainability of China’s vaccine diplomacy is questionable because of the Sino-American geopolitical competition and doubts over the efficacy of China’s vaccines. The escalation of power rivalry between China and the U.S. and the concerns over the efficacy of China’s vaccines forebode the gloomy future of China’s vaccine diplomacy.

show abstract

Section: Discussionmentioning

confidence: 99%

China’s Vaccine Diplomacy and Its Implications for Global Health Governance

2022

View full text Add to dashboard Cite

show abstract

“…В 2008 г. заместитель госсекретаря США по вопросам публичной дипломатии и общественным делам Дж.К. Глассман впервые употребил термин «публичная дипломатия 2.0», под которым понимается новый подход к выстраиванию коммуникации 29 . По данным за 2018 г., в странах ЦА интернетом пользуются около 36 млн человек (приблизительно 68% всего населения региона) 30 Во-первых, требуется последовательное укрепление гуманитарных связей, сформированных за последние два десятилетия.…”

Section: публичная дипломатия китая в ц ентральной азииunclassified

“…Поскольку первая вспышка заболеваемости вирусом нового типа была зафиксирована в китайской провинции Ухань, академическое сообщество проявило повышенный интерес к китайской дипломатии, вынужденной адаптироваться к этим условиям. Зарубежные исследователи отметили, что эффективные меры борьбы с новой коронавирусной инфекцией внутри страны позволили Китаю провести ряд дипломатических мероприятий для восстановления своего национального имиджа, включая предоставление развивающимся и некоторым развитым странам необходимой медицинской помощи и вакцин («вакцинная дипломатия») Kobierecka, 2022].…”

Section: Introductionunclassified

PRC’s Public Diplomacy Practice in Central Asia: Current Situation, Challenges and Prospects

Wang

2023

jour

View full text Add to dashboard Cite

The Central Asian region, with its rich reserves of energy resources and unique geopolitical position, is of particular importance for the modern foreign policy strategy of the People’s Republic of China. At the same time, the PRC’s public diplomacy and soft power in the Central Asian republics remain relatively understudied, despite the overall emphasis given to these issues by the Chinese researchers. It is this gap that this paper is partly intended to fill. The first section of the paper examines the evolution of the discourse on ‘public diplomacy’ in China and its perception in the Chinese academic community. The second section identifies the reasons for mainstreaming public diplomacy agenda in China’s foreign policy towards the Central Asian countries in recent years. The author shows that enhancement of economic and political cooperation between China and regional countries was not matched by a concurrent improvement of the China’s public image, on the contrary there has been a noticeable rise in Sinophobia. It was against this background that the PRC turned its attention to the use of public diplomacy tools as it launched the Belt and Road Initiative. The third section outlines the main thrusts of the Chinese public diplomacy in the region, including PR-diplomacy, media-diplomacy and humanitarian diplomacy. The final section identifies both the endogenous and exogenous challenges faced by the PRC’s public diplomacy in the Central Asian countries. The author argues that the competitiveness and effectiveness of China’s public diplomacy could be increased through expanding cooperation in the humanitarian sphere, implementation of digital technologies and media 2.0, as well as by increased engagement of non-governmental commercial and non-profit actors in interaction with the regional public. Either way, the author concludes that the Central Asian region will play an increasing role in the Chinese public diplomacy.

show abstract

“…A rich literature elaborates on the internal and external factors that have weakened the WHO’s role as a global health leader (Burton, 2020; Fazal, 2020; Gostin et al, 2015, 2020; Van Hecke et al, 2021). Some of these studies (Fazal, 2020; Gostin et al, 2020) intersect with another stream of research which concurs on the emerging attractiveness of China as a partner to developing countries in tackling the global health crisis (Kobierecka, 2023; Lee, 2023). However, we observe two major gaps in this literature.…”

Section: Introductionmentioning

confidence: 99%

COVAX versus Sinovac: A test for the legitimacy of the World Health Organization in South East Asia

Landini,

Sicurelli

2023

The British Journal of Politics and International Relations

View full text Add to dashboard Cite

The coronavirus disease-19 crisis has challenged the legitimacy of the World Health Organization as an actor in global health governance and provided the opportunity for China to emerge as a partner of developing countries in facing global pandemics. In this respect, South East Asia represents an emblematic region for testing the legitimacy of the international organisation vis-a-vis the emerging power. This article adopts a sociological interpretation of legitimacy and provides an empirical analysis of the discursive and non-discursive practices in South East Asian countries concerning support to – and criticism against – the World Health Organization–led initiative COVAX. It provides a variegated and dynamic picture of perceptions of the international organisation in the region. Our results partly call into question representations of the weakening of the legitimacy of the World Health Organization in favour of China’s leading role. Finally, the article recognises the need to analyse legitimacy of the World Health Organization in connection both with the broader geopolitical positioning of governments receiving the Organization’s aid and with the levels of trust in the government of the public in competing partners in dealing with global pandemics.

show abstract

Post-covid China: ‘vaccine diplomacy’ and the new developments of Chinese foreign policy

Cited by 18 publications

References 24 publications

China’s Vaccine Diplomacy and Its Implications for Global Health Governance

China’s Vaccine Diplomacy and Its Implications for Global Health Governance

PRC’s Public Diplomacy Practice in Central Asia: Current Situation, Challenges and Prospects

COVAX versus Sinovac: A test for the legitimacy of the World Health Organization in South East Asia

Contact Info

Product

Resources

About